| Primary |
| Type 2 Diabetes Mellitus |
27.0% |
| Diabetes Mellitus |
13.7% |
| Type 1 Diabetes Mellitus |
11.0% |
| Insulin-requiring Type 2 Diabetes Mellitus |
8.4% |
| Insulin-requiring Type Ii Diabetes Mellitus |
8.4% |
| Hypertension |
7.3% |
| Product Used For Unknown Indication |
7.0% |
| Diabetes Mellitus Insulin-dependent |
2.1% |
| Cardiac Disorder |
1.8% |
| Drug Use For Unknown Indication |
1.5% |
| Insomnia |
1.5% |
| Hypersensitivity |
1.4% |
| Ill-defined Disorder |
1.4% |
| Gestational Diabetes |
1.3% |
| Hypothyroidism |
1.3% |
| Gastric Ulcer |
1.1% |
| Hepatic Function Abnormal |
1.1% |
| Anaemia |
1.0% |
| Depression |
1.0% |
| Blood Cholesterol Increased |
0.8% |
|
| Hypoglycaemia |
14.4% |
| Blood Glucose Increased |
11.9% |
| Hepatic Function Abnormal |
5.9% |
| Tremor |
5.9% |
| Blood Glucose Decreased |
5.1% |
| Hypoglycaemic Coma |
5.1% |
| Hypoglycaemic Unconsciousness |
5.1% |
| Anti-insulin Antibody Positive |
4.2% |
| Drug Ineffective |
4.2% |
| Product Quality Issue |
4.2% |
| Suicide Attempt |
4.2% |
| Blood Glucose Fluctuation |
3.4% |
| Cerebrovascular Accident |
3.4% |
| Diabetic Ketoacidosis |
3.4% |
| Hepatic Enzyme Increased |
3.4% |
| Pruritus |
3.4% |
| Skin Test Positive |
3.4% |
| Urinary Tract Infection |
3.4% |
| Vomiting |
3.4% |
| Device Failure |
2.5% |
|
| Secondary |
| Type 2 Diabetes Mellitus |
22.6% |
| Type 1 Diabetes Mellitus |
19.5% |
| Diabetes Mellitus |
13.9% |
| Insulin-requiring Type Ii Diabetes Mellitus |
11.4% |
| Diabetes Mellitus Insulin-dependent |
6.7% |
| Insulin-requiring Type 2 Diabetes Mellitus |
6.0% |
| Hypertension |
5.7% |
| Cerebral Infarction |
1.9% |
| Drug Use For Unknown Indication |
1.3% |
| Constipation |
1.3% |
| Hyperlipidaemia |
1.3% |
| Gastric Ulcer |
1.2% |
| Gastritis |
1.2% |
| Product Used For Unknown Indication |
1.2% |
| Diabetic Neuropathy |
1.0% |
| Angina Pectoris |
0.8% |
| Benign Prostatic Hyperplasia |
0.8% |
| Depression |
0.8% |
| Rheumatoid Arthritis |
0.8% |
| Blood Cholesterol |
0.7% |
|
| Hypoglycaemia |
15.9% |
| Blood Glucose Increased |
9.4% |
| Blood Glucose Fluctuation |
8.8% |
| Hepatic Function Abnormal |
7.1% |
| Drug Hypersensitivity |
6.5% |
| Hypoglycaemic Unconsciousness |
6.5% |
| Rash |
5.9% |
| Diabetes Mellitus Inadequate Control |
4.1% |
| Wrong Drug Administered |
4.1% |
| Product Quality Issue |
3.5% |
| Reflux Oesophagitis |
3.5% |
| Injection Site Reaction |
2.9% |
| Intentional Overdose |
2.9% |
| Liver Disorder |
2.9% |
| Nausea |
2.9% |
| Vomiting |
2.9% |
| Weight Decreased |
2.9% |
| Glycosylated Haemoglobin Increased |
2.4% |
| Hepatic Enzyme Increased |
2.4% |
| Influenza |
2.4% |
|
| Concomitant |
| Diabetes Mellitus |
19.9% |
| Product Used For Unknown Indication |
17.5% |
| Drug Use For Unknown Indication |
17.0% |
| Hypertension |
10.5% |
| Type 2 Diabetes Mellitus |
7.7% |
| Prophylaxis |
3.7% |
| Type 1 Diabetes Mellitus |
3.3% |
| Diabetes Mellitus Non-insulin-dependent |
2.8% |
| Hyperlipidaemia |
2.3% |
| Cardiac Failure |
2.1% |
| Depression |
1.6% |
| Insomnia |
1.5% |
| Acquired Immunodeficiency Syndrome |
1.4% |
| Constipation |
1.4% |
| Renal Failure Chronic |
1.4% |
| Blood Cholesterol Increased |
1.3% |
| Renal Transplant |
1.2% |
| Panic Disorder |
1.1% |
| Cardiac Disorder |
1.1% |
| Prophylaxis Against Transplant Rejection |
1.1% |
|
| Weight Decreased |
19.2% |
| Vomiting |
8.3% |
| Hypoglycaemia |
8.0% |
| Blood Glucose Increased |
5.4% |
| Death |
5.4% |
| Rhabdomyolysis |
4.7% |
| Weight Increased |
4.7% |
| Renal Failure |
4.3% |
| White Blood Cell Count Decreased |
4.3% |
| Pneumonia |
4.0% |
| Nausea |
3.6% |
| Rash |
3.6% |
| Insulin Resistance |
3.3% |
| Suicide Attempt |
3.3% |
| Thrombocytopenia |
3.3% |
| Vision Blurred |
3.3% |
| Decreased Appetite |
2.9% |
| Myocardial Infarction |
2.9% |
| Palpitations |
2.9% |
| Drug Ineffective |
2.5% |
|
